Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report)’s stock price gapped up before the market opened on Monday . The stock had previously closed at $15.60, but opened at $16.38. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $16.00, with a volume of 3,938 shares.
Analyst Ratings Changes
Several research firms recently weighed in on TLX. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th. UBS Group initiated coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They set a “buy” rating and a $21.00 price target on the stock.
Check Out Our Latest Report on Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited American Depositary Shares Trading Up 3.7 %
Telix Pharmaceuticals Limited American Depositary Shares Company Profile
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
Read More
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- Stock Average Calculator
- 3 Must-Hold Stocks with Double-Digit Upside for 2025
- What is an Earnings Surprise?
- Micron: Why Now Is the Time to Be Brave
- How to Use the MarketBeat Stock Screener
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
